The NADPH Oxidase Family and its Inhibitors

作者：Paulina Kleniewska, Aleksandra Piechota-Polańczyk, Beata Skibska, Anna Gorąca · 发表于：Archivum Immunologiae et Therapiae Experimentalis · 年份：2012 · DOI：10.1007/s00005-012-0176-z · 被引用次数：129 · 研究领域：Neutrophil, Myeloperoxidase and Oxidative Mechanisms、Nitric Oxide and Endothelin Effects、Neuroinflammation and Neurodegeneration Mechanisms

The classical nicotinamide adenine dinucleotide phosphate (NADPH) oxidase was originally detected in neutrophils as a multicomponent enzyme that catalyzes the generation of superoxide from oxygen and the reduced form of NADPH. This enzyme is composed of two membrane-bound subunits (p22phox and gp91phox), three cytosolic subunits (p67phox, p47phox, and p40phox) and a small G-protein Rac (Rac1 and Rac2). Recently, it has been demonstrated that there are several isoforms of nonphagocytic NADPH oxidase. Endothelial cells, vascular smooth muscle cells or adventitial fibroblasts possess multiple isoforms of this enzyme. The new homologs, along with gp91phox are now designated the Nox family of NADPH oxidases and are key sources of reactive oxygen species in the vasculature. Reactive oxygen species play a significant role in regulating endothelial function and vascular tone. However, besides the participation in the processes of physiological cell, these enzymes can also be the perpetrator of oxidative stress that causes endothelial dysfunction. This review summarizes the current state of knowledge of the structure and functions of NADPH oxidase and NADPH oxidase inhibitors in the treatment of disorders with endothelial damage.